Position Papers

  • Action on Smoking and Health. ASH Briefing on e-cigarettes. 2013. http://ash.org.uk/files/documents/ASH_715.pdf 
  • AIDUCE. The future of Vaping in the European Union. 2013. http://www.aiduce.fr/AIDUCE_ENVI_EN.pdf 

  • Snowdon, Christopher. Free Market Solutions in Health. The case of nicotine. IEA Current Controversies Paper No. 47, 2013. http://www.iea.org.uk/sites/default/files/in-the-media/files/The%20Case%20of%20Nicotine.pdf

  • Should e-cigarettes be regulated as a medicinal device? Peter Hajek,Jonathan Foulds,Jacques Le Houezec,David Sweanor,Derek Yach. The Lancet Respiratory Medicine - 1 August 2013 ( Vol. 1, Issue 6, Pages 429-431 )Bates, Clive; Stimson,

  • Stimson, Gerry. Costs and burdens of medicines regulation for e-cigarettes. 20 September 2013 [http://nicotinepolicy.net/documents/reports/Impacts of medicines regulation - 20-09-2013.pdf]

  • ASH. Will you permit or prohibit e-cigarette use on your premises? October 2013. [http://www.ash.org.uk/files/documents/ASH_900.pdf]
  • Morven Dialogues, 2013: Sponsored by the Institute for Environmental Negotiation, University of Virginia: Core principles concerning the implementation of effective and workable tobacco, nicotine, and alternative products policies for reducing disease and death from tobacco use. [http://nicotinepolicy.net/documents/position_papers/MorvenCorePrinciplesfinal.pdf]

  • Frank Dukes, Tanya Cobb and Scott Ballin: How Should FDA Implement a More Rational and Workable Approach to Regulating Tobacco, Nicotine, and Alternative Harm Reduction Products? Food and Drug Law Institute, VOLUME 3, ISSUE 18. OCTOBER 23, 2013. [http://nicotinepolicy.net/documents/poistion_papers/FDLIArticleTobNicReg.pdf]
     
  • Rachel Grana, Neal Benowitz, Stanton A. Glantz: Background Paper on E-cigarettes (Electronic Nicotine Delivery Systems). Center for Tobacco Control Research and Education, University of California, San Francisco. Prepared for World Health Organization Tobacco Free Initiative. December 2013 [http://nicotinepolicy.net/documents/position_papers/Grana_Glantz_WHO_ENDS_Report_Dec2013.pdf]

  • Konstantinos E. Farsalinos, Gerry V. Stimson. Is there any legal and scientific basis for classifying electronic cigarettes as medications? The International journal on drug policy 7 April 2014 (Article in Press DOI: 10.1016/j.drugpo.2014.03.003)

    Abstract: The rapid growth in the use of electronic cigarettes has been accompanied by substantial discussions by governments, international organisations, consumers and public health experts about how they might be regulated. In the European Union they are currently regulated under consumer legislation but new legislation will regulate them under the Tobacco Products Directive. However, several countries have sought to regulate them under medicines regulations. These claims have been successfully challenged in 6 court cases in European states. Under European legislation a product may be deemed to be a medicine by function if it is used in or administered to human beings either with a view to restoring, correcting or modifying physiological functions by exerting a pharmacological, immunological or metabolic action, or to making a medical diagnosis. It is a medicine by presentation if it is presented (e.g. by a manufacturer or distributor) as having properties for treating or preventing disease in human beings. We assess the legal and scientific basis for the claim that electronic cigarettes should be regulated as medicines. We conclude that they are neither medicine by function nor necessarily by presentation The main reason for their existence is as a harm reduction product in which the liking for and/or dependence on nicotine is maintained, and adoption of use is as a substitute for smoking and not as a smoking cessation product. In reality, they are used as consumer products providing pleasure to the user. They are not used to treat nicotine addiction or other disease, but to enable continued use of nicotine. Their use is adjusted individually by each consumer according to his or her perceived pleasure and satisfaction. Gaps in current regulation regarding safety and quality can be met by tailored regulations.

NSP-Logo03A-290x166

Contribute

If there are documents, web links or other resources you'd like to notify us about, please email us at
This email address is being protected from spambots. You need JavaScript enabled to view it.